Cargando…
B cell targeted therapies
Although the precise pathogenesis of rheumatoid arthritis (RA) remains unclear, many cell populations, including monocytes, macrophages, endothelial cells, fibroblasts and B cells, participate in the inflammatory process. Ongoing research continues to evaluate the critical roles played by B cells in...
Autor principal: | Keystone, Edward |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833972/ https://www.ncbi.nlm.nih.gov/pubmed/15960817 http://dx.doi.org/10.1186/ar1738 |
Ejemplares similares
-
Rituximab for Rheumatoid Arthritis
por: Cohen, Marc D., et al.
Publicado: (2015) -
B‐cell targeted therapy of pemphigus
por: Yamagami, Jun
Publicado: (2022) -
B Cell Tolerance and Targeted Therapies in SLE
por: Parodis, Ioannis, et al.
Publicado: (2023) -
B-cell activating factor targeted therapy and lupus
por: Boneparth, Alexis, et al.
Publicado: (2012) -
Targeted Therapies in Adult B-Cell Malignancies
por: Rossi, Jean-François
Publicado: (2015)